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ABSTRAK
Terapi Oksigen Hiperbaric (TOH) dikesan dapat meningkatkan pengoksigenan 
dan kesan anti-mikrob yang berpotensi meningkatkan penyembuhan ulser kronik. 
Kajian ini bertujuan menilai kesan TOH dalam ulser kaki diabetik (UKD) yang 
kronik. Seramai enam puluh pesakit dikelaskan mengikut Wagner 1, 2 atau 3 ulser 
kaki diabetik kronik dan dibahagikan secara rawak kepada dua kumpulan; TOH 
dan kawalan. Semua pesakit menjalani rawatan piawai untuk UKD, tetapi bagi 
kumpulan TOH menjalani 20 sesi TOH, yang berlangsung selama 80 - 90 minit 
pada 2.5 atmosfera mutlak (ATA) setiap sesi. Bilangan sel putih dan tahap protein 
C-reaktif telah diambil semasa kemasukan wad, pada minggu kedua dan keempat 
rawatan. Saiz luka didokumentasikan pada setiap susulan sehingga enam bulan 
susulan. Soal selidik SF-36 selepas pesakit menjalani terapi oksigen hiperbarik 
telah digunakan untuk mengukur kualiti kehidupan dan kesihatan. Pengurangan sel 
putih dan protin C-reaktif dalam kumpulan TOH adalah ketara sepanjang rawatan 
berbanding kumpulan kawalan (p = 0.046 dan p = 0.039 masing-masing). Seramai 
26 pesakit (86.7%) daripada kumpulan TOH telah mencapai penyembuhan ulser 
pada enam bulan susulan, manakala hanya 18 pesakit (60%) dalam kumpulan 
kawalan telah sembuh sepenuhnya pada enam bulan susulan. Pesakit yang 
dirawat dengan TOH menunjukkan konstituen kesihatan mental dan fizikal jauh 
lebih baik dalam soal selidik kualiti kehidupan. Adalah ditekankan bahawa TOH 
adalah terapi tambahan kepada rawatan ulser kaki diabetik yang kronik dalam 
mempercepatkan penyembuhan luka bagi memastikan kualiti hidup pesakit yang 
lebih baik.
Kata kunci: pengoksigenan, kualiti kehidupan, penyembuhan luka 
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patients with diabetic foot problems, 
in particularly those with previous 
major amputation history, have worse 
quality of life in the environment 
domain such as financial, quality and 
standard of living with worse stress 
readaptation ability. It is believed that 
late complications often affect patients 
by hindering social interactions hence, 
isolation, unemployment as a results of 
reduce mobility and ultimately results 
in financial problems (Herber et al. 
2007; Goodridge et al. 2005).
 Cellular processes in stages of wound 
healing such as cell metabolism, 
proliferation, and revascularization 
crucially requires oxygen. Systemic 
ABSTRACT
Hyperbaric oxygen therapy (HBOT) was established to increase oxygenation and 
antimicrobial effect that potentially improve the healing of chronic ulcer. Present 
study aim to assess the effects of HBOT in chronic diabetic foot ulcer (DFU). A 
total of sixty patients classified according to Wagner 1, 2 or 3 chronic diabetic 
foot ulcers, were recruited and subsequently divided randomly into two groups; 
HBOT and control group. All patients underwent the standard treatment for DFU, 
but for the HBOT group, underwent 20 HBOT sessions, each lasted 80 – 90 mins 
at 2.5 atmospheres absolute (ATA). White cell count (WCC) and C-reactive protein 
(CRP) levels were taken during inclusion, at second and fourth week of treatment. 
Wound sizes were documented at each follow up until six months follow up. 
SF-36 at one-month post hyperbaric oxygen therapy was used to measure the 
health-related quality of life. Reduction of WCC and CRP in HBOT group were 
significant throughout the treatment (p=0.046 and p=0.039, respectively). A total 
of 26 patients (86.7%) from the HBOT group achieved complete ulcer healing 
at six months’ follow-up, while 18 patients (60%) in the control group’s ulcer 
healed completely. Patients treated with HBOT had significantly better mental and 
physical health constituent of quality of life. It must be emphasised that HBOT is 
an adjunctive therapy to the standard management of chronic DFU in accelerating 
wound healing for a better quality of life.
Keywords: oxygenation, quality of life, wound healing
INTRODUCTION
Preceding published researches of 
health-related quality of life (QOL) 
have shown distinct low quality of 
life in patients suffering from diabetic 
foot problems (Kinmond et al. 2003; 
Ribu & Wahl 2004). These patients 
experience relentless constraint on 
daily life basis due to the ulcer. These 
patients are often rendered helpless 
haunted by concern for the future, 
greater frustration with their lives, 
higher levels of depression and poorer 
psychosocial adjustment to illness 
(Kinmond et al. 2003; Ribu & Wahl 
2004). Fejfarová et al. (2014) noted that 
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hyperbaric oxygen therapy (HBOT) was 
suggested to improve long term healing 
in chronic diabetic ulcers that have 
not improved with pertinent therapy 
(Lipsky & Berendt 2010). Oxygen 
therapy has demonstrated a vital role 
in increased antimicrobial activity, 
synthesis of collagen that enhances 
wound tensile strength and growth 
factor signal transduction (Eggleton et 
al. 2015). Furthermore, not only that 
it enhances neutrophil killing ability, 
hyperbaric oxygen also reduces local 
inflammation during revascularization 
of wound tissue by hindering 
inflammatory cell (neutrophil)–
endothelial cell interaction (Eggleton 
et al. 2015; Kendall et al. 2013).
 HBOT augments the apoptosis of 
phagocytes which interrupts the build-
up of potentially necrotic cell debris 
(Almzaiel et al. 2013).
 Apart from that, it also encourages 
angiogenesis and augment fibroblast 
activity (Kranke et al. 2004; Barnes 
2006). Theoretically, HBOT appears to 
enhance the healing of ischemic foot 
ulcers in diabetic patients. 
 Londahl et al. (2010) conducted a 
randomized controlled trial of a total of 
94 patients with Wagner grade 2, 3 or 
4 ulcer were recruited. A total of 57% 
of these patients receiving HBOT had 
healed ulcer at 1-year follow up, while 
in the placebo group, only 29% had 
achieve healing. Hyperbaric sessions 
were conducted for 8 to 10 weeks (40 
sessions in total, each session was 90 
minutes at 2.5 ATA). The main aim was 
healed ulcer with complete epithelial 
regeneration. Patients divided 
randomly into two treatment groups 
were similar at initial study. More than 
half had undergone vascular surgery 
for lower limb affected.
 Generally, there was no study that 
correlated the effects of hyperbaric 
oxygen therapy with patients’ quality 
of life. The present study aimed to 
assess the effects of HBOT in chronic 
DFU in terms of inflammatory markers, 
wound size reduction and quality of 
life.
MATERIALS & METHODS 
Present study was prospective, 
randomised control and was conducted 
in a tertiary hospital. Patients were 
selected from June 2013 to December 
2014. The selected patients were 
the ones who were admitted due to 
diabetic foot problems.
 Inclusion criteria for this study were 
patients diagnosed with Diabetes 
Mellitus type 1 or 2, and had an ulcer at 
the foot or ankle for at least four weeks 
of duration. Ulcers were classified 
using Wagner classifications system, 
and only type 1, 2 or 3 were included. 
Patients with active infections were 
also included. Exclusion criteria were 
patients who were contraindicated 
for HBOT (e.g. chronic obstructive 
airway disease, middle ear infection 
etc.), patients diagnosed with critical 
limb ischaemia and patients who 
were pregnant or below 18 years of 
age. Patients who had severe medical 
illnesses that could influence the 
quality of life and had underwent 
lower limbs major amputation (level 
Syme’s and above) were also excluded 
from this study.
 Both informed and written consent 
were obtained from patients who 
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fitted the criteria and agreed to be 
included in the study. Monofilament 
and ankle brachial pressure index 
was done to gauge the severity of 
peripheral neuropathy and peripheral 
arterial disease. The size of ulcers and 
level of inflammatory markers were 
documented at initial presentation 
and at two and four weeks’ review. 
All patients were required to fill-out 
the SF-36 questionnaires after four 
weeks of treatment. SF-36, a self-
reported questionnaire, was used in 
two languages, English and Malay. 
Both language version of SF-36 used in 
this study was translated and validated 
in the Malaysian population. This 
questionnaire covers eight domains/
subscales of quality of life, comprising 
of physical facet (physical health 
components) and psychosocial facet 
(mental health components) of quality 
of life. The physical health consisted 
of Physical Functioning, Physical 
Role, Bodily Pain and General Health 
perception, while the mental health 
components are Role Emotional, 
Vitality, Mental Health and Social 
Functioning.
 Patients were assigned randomly 
to two separate groups using a sealed 
envelope with treatment allocation 
inside; HBOT group and control group. 
Treatment in both groups included 
mechanical/chemical debridement, 
antibiotics, wound dressing and off-
loading footwear. Only the HBOT 
group were subjected for hyperbaric 
oxygen therapy. Each session was 
conducted five days a week inmono-
place hyperbaric chamber. (20-
30 treatment sessions). A session 
consisted of a duration of compression 
in air for 5 mins, subsequently at 2.5 
atmosphere absolute (ATA) treatment 
period for 85 mins, and then a 5 mins 
decompression period.
DATA ANALYSIS
SPSS version 22.0 software was 
used to analysed the data collected. 
Descriptive and analytical statistical 
functions of the software was used to 
analysed the demographic and clinical 
characteristics of the study sample. 
Independent t-test using a two-tailed 
test was used to compare mean values 
of continuous data and χ2 test was used 
to compare categorical data in order 
to evaluate inter-group differences. 
Mann Whitney-U test was used to 
compare the median score for each 
SF-36 domain and the summary scores 
between the two groups as the data 
was not normally distributed.
RESULTS
DEMOGRAPHIC DATA
A total of 60 patients were recruited 
and analysed in present study and 
they were randomly divided into two 
groups. These patients were aged 
between 39 to 77 years in which 31 
were males (51.2%) and 29 (48.3%) 
were females. A total of 14 (23.3%) 
of them were active smokers while 
another 46 (76.7%) were non-
smokers, or had quit smoking more 
than 20 years. A total of 25 (41.7%) 
had chronic medical problem (chronic 
kidney disease, retinopathy, ischaemic 
heart disease). Mean duration of the 
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chronic diabetic foot ulcer was 5.2 
months, with 9 (16.7%) were type 1, 
26 (43.3%) were type 2 and 25 (41.7%) 
were type 3 ulcers based on Wagner 
classification system (Table 1).
ANALYSING TOTAL WHITE CELL 
COUNT (TWCC) CHANGES IN 
HBOT AND CONTROL GROUP
During initial presentation, the total 
white cell count (TWCC) was high 
in both groups, but there was no 
significant different statistically at the 
initial presentation (p=0.087). The 
reduction of WCC was seen in both 
groups. However, the trend was more 
steady in the HBOT group until the 
end of treatment at day-30, and mostly 
had normalise. The reduction was 
significant in HBOT group (p=0.046) 
(Figure 1).
ANALYSING C-REACTIVE PROTEIN 
(CRP) CHANGES IN HBOT AND 
CONTROL GROUP
Similar to the TWCC changes, both 
groups have high C-reactive protein 
(CRP) at the initial presentation. 
Table 1: Demographic data of the respondents        
Variables HBOT group (n=30) Control group (n=30) p Value
Age in years (Mean ± s.d.)  54.23 ± 10.20 58.70 ± 11.30  0.081
Gender
  Male 11 (36.70%) 20 (66.70%)
  Female 19 (63.70%) 10 (33.30%)
Wagner Classification
   Type 1 5 (8.33%) 4(6.67%)
   Type 2 13 (21.67%) 13 (21.67%)
   Type 3 12 (20.00%) 13 (21.67%)
Figure 1: White cell count reduction throughout
Figure 2: C-reactive protein (CRP) level reduction 
throughout treatment
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Reduction of CRP protein was observed 
throughout the treatment in HBOT and 
the control group. The reduction trend 
was significant statistically in HBOT 
group which was more constant and 
steady compared to the control group 
(p=0.039) (Figure 2).
ANALYZING ULCER REDUCTION 
IN HBOT AND CONTROL GROUP
During the initial presentation, 
the ulcer size was statistically not 
significant in both groups (p=0.06). 
With the treatment, reduction in size of 
the ulcer was observed in both groups, 
and it was significant (p<0.001) in 
HBOT group (Figure 3). Using Pairwise 
comparison, wound reduction in 
every ten days of measurement was 
significant (p<0.001) in HBOT group 
compared to the control group (Table 
2, Figure 4).
Table 2: Ulcer reduction with treatment
Day of treatment HBOT (in cm2) Control (in cm2) p-Value
D0 10.5 (7.0-14.1) 12.8 (9.2-16.3) 0.060
D10 6.8 (3.6-9.9) 12.1 (8.9-15.2) <0.001
D20 5.1 (2.0-8.1) 11.6 (8.6-15.2) <0.001
D30 3.6 (0.7-6.4) 10.7 (7.8-13.6) <0.001
Independent t-test (*significant if p<0.05)
Figure 3: Photo showing ulcer size reduction after one month of HBOT
Figure 4: Ulcer size reduction throughout 
treatment
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ANALYSING THE QUALITY OF 
LIFE USING SF-36
There was statistically significant 
difference in both group of each 
domain. Patients treated with HBOT 
have better physical and mental 
health. Table 3 shows eight domain 
median scores and the SF-36 two 
summary scales. Mostly, diabetic foot 
ulcer treated without HBOT had lower 
median scores in all of SF-36 domains 
significantly. Hence, diabetic foot ulcer 
treated with HBOT had better quality 
of life. The summary scores showed a 
significantly poor Physical Component 
Summary in patients underwent HBOT 
than those treated with conventional 
treatment alone. This was also seen in 
Mental Component Summary with p 
value equal to 0.001.
DISCUSSION
The present study supports the 
management approach that use 
HBOT as an adjunct to the usual 
DFU treatment for selected diabetic 
patients as it enhances the healing of 
ulcers. HBOT had accelerated ulcer 
healing patients suffering from long-
standing chronic ulcers compared 
to the control group treated with 
conventional treatment alone. All 
sixty patients (thirty in each group) in 
present study were compliant to each 
follow up and assessments. We found 
no significant difference in patients 
who were smoking (p = 0.06) or who 
had chronic medical illnesses such 
as chronic kidney disease, ischaemic 
heart disease, diabetic retinopathy etc. 
(p = 0.087), in both groups of HBOT 
and control group.
 Patients having chronic diabetic 
foot ulcers were susceptible to develop 
recurrent infections, particularly when 
the wound failed to heal. In previous 
study, these patients needed multiple 
surgical debridement, antibiotic 
courses and prolong hospital stay. To 
monitor infections in our study, we 
used reliable infective markers such as 
white cell count and C-reactive protein 
Table 3: The scores of eight SF-36 domains and two summary components








Physical Functioning 60.0 46.7 <0.001
Role Physical 49.0 42.5 0.042
Bodily Pain 59.0 80.9 <0.001
General Health 56.0 38.3 <0.001
Vitality 67.5 49.0 0.005
Social Functioning 50.0 30.0 0.029
Role Emotional 66.7 40.7 <0.001
Mental Health 70.4 51.2 0.028
Physical Component Summary 55.8 50.0 0.001
Mental Health Summary 65.3 53.8 0.001
(Values are expressed as median (25th-75th percentiles) with 0 as poorest health and 100 as the best health)
*significant if p<0.05
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level (Lipsky et al. 2012). The reduction 
of the infective markers (WCC and 
CRP) were seen in both group, which 
were statistically significant (p=0.046 
and 0.039, respectively). We noticed 
that patients in both group developed 
not only recurrent infections due to the 
foot ulcers, but also from other sources 
(e.g. respiratory, urinary tract infections) 
thus exacerbating and influences the 
level of infective markers. Patients who 
developed infection in this study, with 
evidence of clinical and biochemical 
findings were treated accordingly. 
 This explains the steady reduction 
trend of white cell count and C-reactive 
protein in the HBOT group, as the 
elevation of oxygen tension enhances 
the neutrophil oxidative killing of 
bacteria in addition to oxygen being 
directly toxic to anaerobic organisms.
Previous studies supports the use of 
HBOT in the treatment of chronic 
diabetic foot ulcers which significantly 
improve wound healing (Barnes 2006; 
Londahl et al. 2010; Lipsky & Berendt 
2010). We noticed similar outcome 
in this study and it is remarkably 
significant where the wound reduction 
seen in every phases of assessment 
which was conducted in every ten 
days of the treatment. Using pairwise 
comparison, the p value in each phase 
was less than 0.001 compared to the 
control group treated with conventional 
therapy alone. At six months follow 
up, 26 patients (86.7%) in HBOT group 
achieve complete ulcer healing as 
compared to 18 patients (60%) in the 
control group.
 Diabetic complications may greatly 
interfere with the quality of life of 
diabetic patients (Wandell & Tovi 
2000). The effect of foot problems 
to the QOL is the most popularly 
studied using self-reported SF-36 
questionnaire. There were significantly 
different scores of all domains and 
the two summary scales in the SF-36 
two groups. The Physical Functioning 
domain governs all physical tasks 
such as bending, stretching, walking 
and climbing stairs without limitation 
while the Role Physical domain tests 
on predicaments of tasks or other daily 
activities resulting from the physical 
health. The control group scored 
significantly, indicating severe and 
relentless restrictions with mobility. 
This is probably due to inability to 
mobilize secondary to non-weight-
bearing regimen from foot ulcer. 
Mental health was not as severely 
impaired as some of the components 
in physical health. Our findings are 
in agreement of several studies that 
also focus on quality of living among 
patients struggling Diabetic Foot Ulcer. 
Such studies are by Valensi et al. (2005) 
and Ribu et al. (2006), of which both 
studies use the SF-36 Questionnaires 
and these two studies were both cross-
sectional and observational design, 
only that Ribu et al. (2006) compared 
the scores of patients with DFU ulcer 
score to the general population without 
Diabetes where as Valensi et al. (2005) 
compared the QOL among Diabetic 
patients with and without DFU. These 
studies however, did not measure 
HBOT influence on ulcer healing and 
quality of living. Another study with 
results consistent to present study was 
done by Mazlina et al. (2011) and it 
compared the health-related quality 
of life in patients with DFU to diabetic 
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patients without DFU, using the SF-36 
questionnaires, it was observed that 
the two domains of physical health 
such as physical functioning and 
role physical domain were affected 
negatively great in patients with DFU. 
They also observed that mental health 
was affected but not as severely as the 
physical component.
 Mental health measures the level 
of happiness, general well-being 
and constraints that emotional issue 
drawback on the degree of task one is 
able to carry out. The probable cause 
for patients in the control group having 
significantly low mental health score 
was attributed to having doubts as to 
when or whether the foot problems 
will heal. They may experience 
poorer psychosocial adjustments and 
experience living constraints.
 Admittedly, the sample size for the 
present study was small due to this 
is pilot study in the country. It aims 
to study the effects of DFU towards 
quality of life but also the outcome 
of HBOT. Therefore, a bigger sample 
size is recommended for future study. 
We also had limitation to control each 
single dressing to be used in both 
HBOT and control groups.
CONCLUSION
In conclusion, it must be emphasised 
that HBOT is an adjunctive therapy 
to many other components essential 
in accelerating wound healing and in 
achieving better quality of life in chronic 
non-healing diabetic foot ulcer. The 
results of present and precedent should 
provide impetus and basis for larger 
multicentre prospective, randomized, 
double-blinded controlled studies in 
assessing the outcome of HBOT in 
healing of diabetic foot ulcers.
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